US Tiger Securities, Inc.
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination 2024-03-12 04:30
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination 2024-02-10 05:30
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination 2024-01-12 05:30
Denali Capital Acquisition Corp. Announces Postponement of Extraordinary General Meeting From Thursday, January 4, 2024 to Tuesday, January 9, 2024 2023-12-30 05:30
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination 2023-12-12 05:30
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination 2023-11-11 05:30
Denali Capital Acquisition Corp. Announces Shareholder Approval of Extension of Deadline to Complete Business Combination 2023-10-12 04:30
TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination 2023-08-19 04:30
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete an Initial Business Combination 2023-07-13 19:00
Denali Capital Acquisition Corp. Announces Intention to Extend Deadline to Complete an Initial Business Combination 2023-07-08 04:58
TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination 2023-05-20 04:30
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete an Initial Business Combination 2023-04-13 04:30
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete an Initial Business Combination 2023-04-07 04:30
Feutune Light Acquisition Corporation Announces Intention to Extend the Deadline for an Initial Business Combination 2023-03-21 04:30
TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination 2023-03-18 04:30
Estrella Biopharma Announces FDA Clearance of IND Application for Phase I/II Clinical Trial (Starlight-1) of EB103, a CD19-Targeted ARTEMIS® T Cell Therapy, to Patients with B-Cell Lymphomas 2023-03-09 05:15
Longevity Biomedical, Inc. and Denali Capital Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity 2023-01-26 19:30
TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination 2023-01-21 05:33
Fortune Rise Acquisition Corporation Confirms to Extend Period to Consummate Initial Business Combination 2022-11-02 05:04
Estrella Biopharma, Inc., a biopharmaceutical company to Become a Publicly Traded Company Via Merger with TradeUP Acquisition Corp. 2022-10-03 19:27
1 2